(Q48222004)

9 February 2018

title

Both 5-HT1B and 5-HT1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis. (English)

1 reference

9 February 2018

author

Christian Waeber

4

1 reference

9 February 2018

author name string

Mitsikostas DD

1

1 reference

9 February 2018

Sanchez del Rio M

2

1 reference

9 February 2018

Moskowitz MA

3

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

9 February 2018

European Journal of Pharmacology

published in

1 reference

9 February 2018

volume

369

1 reference

9 February 2018

page(s)

271-277

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

A single point mutation increases the affinity of serotonin 5-HT1D alpha, 5-HT1D beta, 5-HT1E and 5-HT1F receptors for beta-adrenergic antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Cloning and characterization of the guinea pig 5-HT1F receptor subtype: a comparison of the pharmacological profile to the human species homolog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

5-HT1 receptor agonists attenuate the naloxone-induced jumping behaviour in morphine-dependent mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

5HT1B and 5HT1D receptor mRNA differential co-localization with peptide mRNA in the guinea pig trigeminal ganglion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Evidence for the presence of 5-HT1B receptor messenger RNA in neurons of the rat trigeminal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Involvement of 5-HT1B receptors in the anticonflict effect of m-CPP in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Human arterial constrictor serotonin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Effect of antimigraine drugs on dural blood flows and resistances and the responses to trigeminal stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Sumatriptan. An updated review of its use in migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

[3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

5-Hydroxytryptamine1A and 5-hydroxytryptamine1B receptors stimulate [35S]guanosine-5'-O-(3-thio)triphosphate binding to rodent brain sections as visualized by in vitro autoradiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

The serotonin 5-HT1D receptor: a progress review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

Human 5-HT1F receptor-stimulated [35S]GTPgammaS binding: correlation with inhibition of guinea pig dural plasma protein extravasation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900067-9

10.1016/S0014-2999(99)00067-9

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

10225363

1 reference

9 February 2018